Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Justine Dao, n/a

Debiopharm International, Switzerland

Disclosure(s): Debiopharm International: Salary

Poster(s):

(P-65) Results from A Phase 2 Clinical Trial for Treatment of Bone And Joint Infections with Afabicin, A First-in-Class Selective Anti-Staphylococcal Antibiotic

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-1229) Assessment of Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment for the Anti-Staphylococcal Antibiotic Afabicin

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT